$0.365100
-0.36-97.26%
At close: Jul 19, 2:48 PM EDT
15 minutes delayed
Comments
Loading...
Calithera Biosciences
CALAOTCEM
Calithera Biosciences (OTC:CALA) Stock, Earnings Estimates, EPS, And Revenue
Calithera Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-2.010
Quarterly Revenue
$0K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Calithera Biosciences using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CALA | Calithera Biosciences | -$3.00 | -$1.93 | -$2.01 | -4.15% | $6.75M | — | $0.00 | — | 11/14/2022 | Get Alert |
| CALA | Calithera Biosciences | -$3.80 | -$2.65 | -$1.59 | 40.00% | $3.00M | — | $0.00 | — | 08/15/2022 | Get Alert |
| CALA | Calithera Biosciences | -$5.60 | — | -$3.60 | — | $0.00 | — | $0.00 | — | 05/10/2022 | Get Alert |
| CALA | Calithera Biosciences | -$6.40 | -$4.80 | -$4.80 | 0.00% | $0.00 | — | $0.00 | — | 03/31/2022 | Get Alert |
| CALA | Calithera Biosciences | -$6.40 | -$4.60 | -$3.00 | 34.78% | $0.00 | — | $6.75M | — | 11/09/2021 | Get Alert |
| CALA | Calithera Biosciences | -$5.80 | -$4.80 | -$3.80 | 20.83% | $0.00 | — | $3.00M | — | 08/05/2021 | Get Alert |
| CALA | Calithera Biosciences | -$7.60 | -$5.00 | -$5.60 | -12.00% | $0.00 | — | $0.00 | — | 05/06/2021 | Get Alert |
| CALA | Calithera Biosciences | -$7.80 | -$6.40 | -$6.40 | 0.00% | $0.00 | $600.00K | $0.00 | -100.00% | 03/16/2021 | Get Alert |
| CALA | Calithera Biosciences | -$7.60 | -$6.20 | -$6.40 | -3.23% | $0.00 | — | $0.00 | — | 11/05/2020 | Get Alert |
| CALA | Calithera Biosciences | -$11.60 | -$6.60 | -$5.80 | 12.12% | $0.00 | — | $0.00 | — | 08/10/2020 | Get Alert |
| CALA | Calithera Biosciences | -$12.20 | -$7.20 | -$7.60 | -5.56% | $0.00 | — | $0.00 | — | 05/07/2020 | Get Alert |
| CALA | Calithera Biosciences | -$10.20 | -$7.40 | -$7.80 | -5.41% | $0.00 | $2.50M | $0.00 | -100.00% | 03/11/2020 | Get Alert |
| CALA | Calithera Biosciences | -$10.40 | -$9.00 | -$7.60 | 15.56% | $0.00 | $2.00M | $0.00 | -100.00% | 11/12/2019 | Get Alert |
| CALA | Calithera Biosciences | -$1.80 | -$11.20 | -$11.60 | -3.57% | $17.07M | $2.00M | $0.00 | -100.00% | 08/08/2019 | Get Alert |
Calithera Biosciences (CALA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2022 | 2022-11-14 | $-2.01 | $-1.93 | -4.15 % |
| Jun 2022 | 2022-08-15 | $-1.59 | $-2.65 | 40.0 % |
| Dec 2021 | 2022-03-31 | $-4.80 | $-4.80 | 0.00 % |
| Sep 2021 | 2021-11-09 | $-3.00 | $-4.60 | 34.8 % |
Calithera Biosciences (CALA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2020 | 2021-03-16 | $0 | $600.00K | -100.0 % |
| Dec 2019 | 2020-03-11 | $0 | $2.50M | -100.0 % |
| Sep 2019 | 2019-11-12 | $0 | $2.00M | -100.0 % |
| Jun 2019 | 2019-08-08 | $0 | $2.00M | -100.0 % |
FAQ
When is Calithera Biosciences (OTCEM:CALA) reporting earnings?
Calithera Biosciences ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2022 for Q3.
What were the latest earnings per share (EPS) for Calithera Biosciences (OTCEM:CALA)?
Calithera Biosciences ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2022 for Q3 and the Actual EPS was $-2.01, which missed the estimate of $-1.93.
What were Calithera Biosciences’s (OTCEM:CALA) revenues?
Calithera Biosciences ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2022 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.